knowledge -WSS

knowledge

author：hotspot 2025-10-01 18:03:15 - browse：2344

Hyundai Kia Recall — FILE - A line of 2022 Santa Fe SUV's sit outside a Hyundai dealership Sunday, Sept. 12, 2021, in Littleton, Colo. In documents posted Thursday, Aug. 3, 2023, Hyundai and Kia are telling the owners of nearly 92,000 vehicles in the U.S. to park them outside because an electronic controller in an oil pump can overheat and cause fires. (AP Photo/David Zalubowski, File)The Associated Press

DETROIT -- Hyundai and Kia are telling the owners of nearly 92,000 vehicles in the U.S. to park them outside because an electronic controller in an oil pump can overheat and cause fires.

The affiliated Korean automakers are recalling the vehicles and also are telling owners to park them away from structures until repairs are made.

The recalls cover certain 2023 and 2024 Hyundai Palisades, as well some 2023 Tucson, Sonata, Elantra and Kona vehicles. Affected Kias include the 2023 Soul and Sportage as well as some 2023 and 2024 Seltos vehicles.

The companies say in documents posted Thursday by U.S. safety regulators that a capacitor on a circuit board in the oil pump assembly for the transmission may have been damaged by the supplier during manufacturing. That can cause a short-circuit and increase the risk of a fire.

Kia says it has six reports of melting components but no fires or injuries. Hyundai says it has confirmed four “thermal incidents” and no injuries.

Dealers will inspect and replace the oil pump controller if necessary. Hyundai owners will be notified by letter on Sept. 25. Kia will notify owners starting Sept. 28.

Previous article： Alkermes shareholders re
Next article： Sanofi seeks simpler, safer CRISPR sickle cell cure

WSS

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Maker of FluMist seeks to allow at

Cosmetics set for new safety regulation. Why the industry is on board

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Biden's order seeks to regulate AI risk without stifling innovation

hotspot

knowledge

explore

ChatGPT in medicine: STAT answers readers' burning questions

FDA has safety concerns on CRISPR

23andMe had bad news about my health. I wish a person had delivered it

The pink breast cancer awareness ribbon needs a redesign

Medicare proposal to cover medical devices draws a mixed reaction

First Opinion Podcast: How to protect health care in times of war

In age of alternative facts, a scholarly course on calling out crap

Diversifying clinical trials isn't enough to close racial gaps: study

Drug repurposing or repositioning? The language matters

Why Sanofi got shellacked over its spinoff

hotspot

Google and Epic fight stronger regulation of AI in health care

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Why Sanofi got shellacked over its spinoff

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

AI can’t replace a physician’s gut feeling

Maker of FluMist seeks to allow at

leisure time

knowledge

leisure time

explore